AIKO Biotechnology
Records under this name other than patents AIKO Biotechnology holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 7 of 7 · Back to AIKO Biotechnology
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,061,024 | Combination analgesic employing opioid agonist and neutral antagonist Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,883,817 | Combination analgesic employing opioid and neutral antagonist Formerly held In force · High confidence | In force | High confidence | |
| US 8,748,448 | Combination analgesic employing opioid agonist and neutral antagonist Formerly held Lapsed on the fee record Ended Jun 10, 2026 · From the USPTO record | Lapsed on the fee record | Ended Jun 10, 2026 | From the USPTO record |
| US 6,713,488 | Neutral antagonists and use thereof in treating drug abuse Formerly held Term ended Term ended Mar 15, 2021 · From the USPTO record | Term ended | Term ended Mar 15, 2021 | From the USPTO record |
| US 6,270,979 | Methods for anti-addictive narcotic analgesic treatments Formerly held Lapsed on the fee record Ended Aug 7, 2009 · From the USPTO record | Lapsed on the fee record | Ended Aug 7, 2009 | From the USPTO record |
| US 5,882,944 | Methods for G protein coupled receptor activity screening Formerly held Term ended Term ended no later than Mar 16, 2019 · Low confidence | Term ended | Term ended no later than Mar 16, 2019 | Low confidence |
| US 6,007,986 | Methods for anti-addictive narcotic analgesic activity screening Formerly held Term ended Term ended no later than Dec 28, 2019 · Low confidence | Term ended | Term ended no later than Dec 28, 2019 | Low confidence |